Observations on the use of seprafilm on the brachial plexus in 249 operations for neurogenic thoracic outlet syndrome.
OBJECTIVE
Seprafilm was initially used successfully as a membrane to reduce abdominal adhesions. Subsequently it was tried in a number of other areas to reduce postoperative scarring. Seprafilm was employed in this study to see if it would reduce postoperative scarring after supraclavicular thoracic outlet decompression for neurogenic thoracic outlet syndrome (NTOS).


METHODS
There were 249 operations for primary NTOS (185) and recurrent NTOS (64). Seprafilm was applied to the nerve roots at the end of each procedure. Diagnosis was established by careful history and extensive physical exam consisting of several provocative maneuvers. Scalene muscle block confirmed the diagnosis.


RESULTS
Success rates for primary operations, 1-2 years postoperation were 74% for scalenectomy without first rib resection and 70% for scalenectomy with first rib resection. For reoperations, success rate for scalenectomy and neurolysis after transaxillary rib resection was 78% whereas success rate for neurolysis after supraclavicular scalenectomy was 68%. Seprafilm did not significantly improve overall results compared to our results 15 years ago, although in reoperations there was a trend toward improvement with Seprafilm. Observations in 10 reoperations after use of Seprafilm revealed that there were fewer adhesions between fat pad and nerve roots, making it much easier to find the nerve roots. Recurrence was because of scar formation around individual nerve roots.


CONCLUSIONS
Seprafilm made reoperations easier by reducing scarring between scalene fat pad and brachial plexus. However, it did not prevent scar tissue forming around the individual nerve roots nor did it significantly lower the failure rate for primary operations. The trend supported the use of Seprafilm in reoperations.
Sanders
Richard J
RJ
University of Colorado Health Sciences Center, Denver, CO, US. rsanders@ecentral.com
Hammond
Sharon L
SL
Rao
Neal M
NM
J Surg Res. 2003 Aug;113(2):195-200
12957129
Dis Colon Rectum. 2003 Oct;46(10):1310-9
14530667
Eur J Obstet Gynecol Reprod Biol. 2005 Dec 1;123(2):244-8
15950364
Br J Plast Surg. 2003 Jun;56(4):342-7
12873461
Am J Surg. 2004 Apr;187(4):505-10
15041500
J Thorac Cardiovasc Surg. 2005 Feb;129(2):359-63
15678047
J Vasc Surg. 1989 Dec;10(6):626-34
2585651
J Neurosurg. 2004 Aug;101(2):295-302
15309922
Surg Today. 2004;34(8):648-51
15290392
J Am Coll Surg. 1996 Oct;183(4):297-306
8843257
Surgery. 1982 Dec;92(6):1077-85
7147186
Ann Plast Surg. 2004 Dec;53(6):560-4
15602253
J Vasc Surg. 1994 Apr;19(4):565-72
8164270
J Vasc Surg. 2005 Jul;42(1):122-8
16012461
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1142-8
16505052
J Laryngol Otol. 2004 Nov;118(11):862-5
15638972
J Cardiovasc Surg (Torino). 1989 May-Jun;30(3):434-44
2745532
J AAPOS. 2004 Feb;8(1):46-9
14970799
Hand Clin. 2004 Feb;20(1):61-70
15005386
Eur J Surg Suppl. 1997;(577):40-8
9076451
Dis Colon Rectum. 2006 Jan;49(1):1-11
16320005
Electromyogr Clin Neurophysiol. 2005 Apr-May;45(3):131-3
15981682